BioRestorative Therapies ...

NASDAQ: BRTX · Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT

BioRestorative Therapies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
547.89K 884.38K 1.71M 21.03M
Short-Term Investments
10.18M 10.18M 13.04M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
148.7K n/a n/a n/a
Receivables
188.4K 19.3K 16K 5K
Inventory
n/a n/a n/a n/a
Other Current Assets
223.23K n/a n/a n/a
Total Current Assets
11.14M 11.39M 15.13M 21.47M
Property-Plant & Equipment
362.94K 507.5K 502.76K 395.8K
Goodwill & Intangibles
623.95K 713.69K 803.44K 589.74K
Total Long-Term Assets
1.14M 1.22M 1.31M 985.54K
Total Assets
12.28M 12.61M 16.43M 22.45M
Account Payables
483.07K 189.39K 170.9K 50.83K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 162.32K 139.33K 58.97K
Other Current Liabilities
2.52M 1.46M 5.4M 106.6K
Total Current Liabilities
3.75M 2.61M 5.98M 363.82K
Long-Term Debt
n/a n/a n/a 191.03K
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 162.32K 492.68K
Total Liabilities
3.75M 2.61M 6.14M 856.5K
Total Debt
n/a 162.32K 301.64K 670.7K
Common Stock
692.00 471.00 369.00 353.00
Retained Earnings
-155.68M -146.7M -136.28M -134.15M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
8.53M 10M 10.29M 21.6M
Total Investments
10.18M 10.18M 13.04M n/a